Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women
Open Access
- 31 December 2007
- journal article
- research article
- Published by Elsevier BV in Fertility and Sterility
- Vol. 88 (6), 1645-1652
- https://doi.org/10.1016/j.fertnstert.2007.01.122
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Effects of Human Immunodeficiency Virus on Protracted Amenorrhea and Ovarian DysfunctionObstetrics & Gynecology, 2006
- Limitations of follicle-stimulating hormone in assessing menopause status: findings from the National Health and Nutrition Examination Survey (NHANES 1999-2000)*Menopause, 2006
- Age of Menopause and Menopausal Symptoms in HIV-Infected WomenAIDS Patient Care and STDs, 2005
- The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the BenchClinical and Vaccine Immunology, 2005
- Follicular phase hormone levels and menstrual bleeding status in the approach to menopauseFertility and Sterility, 2005
- Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiolFertility and Sterility, 2004
- Effect of HIV Infection on Menstrual Cycle LengthJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Serum müllerian-inhibiting substance levels during normal menstrual cyclesFertility and Sterility, 2000
- Female Reproductive Aging Is Marked by Decreased Secretion of Dimeric InhibinJournal of Clinical Endocrinology & Metabolism, 1999
- Serum Follicle-Stimulating Hormone and Luteinizing Hormone Levels in Women Aged 35???60 in the U.S. PopulationMenopause, 1999